⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10835866 | 0.97 | — | — | |
| Carbon Tetrachloride SCHEMBL7950801 | 0.74 | ALDH1A1 (0.33) | — | |
| Chloromethane SCHEMBL6905936 | 0.73 | — | — | |
| SCHEMBL2102476 | 0.69 | — | — | |
| SCHEMBL26629794 | 0.69 | PAX8 (0.32) | — | |
| SCHEMBL9284822 | 0.69 | TSHR (0.38) | — | |
| SCHEMBL11966124 | 0.69 | PAX8 (0.32) | — | |
| Chloromethane SCHEMBL375766 | 0.67 | CYP2C9 (0.35) | — | |
| SCHEMBL7630428 | 0.67 | — | — | |
| SCHEMBL6262239 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1681 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137794-A1 | LIGAND-DRUG CONJUGATE AND USE THEREOF | SYSTIMMUNE INC (US) | 2026-05-21 | — | — | US | claimed |
| CN-119838022-A | Amatoxin conjugates containing branched linkers | 杭州多禧生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| EP-4527416-A1 | LIGAND-DRUG CONJUGATE AND USE THEREOF | SystImmune, Inc. (US) | 2025-03-26 | — | — | EP | claimed |
| CN-113423430-B | Amatoxin conjugates containing branched linkers | 杭州多禧生物科技有限公司 | 2024-12-03 | — | — | CN | claimed |
| WO-2023222019-A9 | LIGAND-DRUG CONJUGATE AND USE THEREOF | 成都百利多特生物药业有限责任公司 | 2024-11-14 | — | — | WO | claimed |
| CN-118557747-A | Conjugates of cell binding molecules and camptothecin analogs | 杭州多禧生物科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| EP-4294453-A1 | LINKER-PAYLOADS AND CONJUGATES THEREOF | Glykos Finland Oy (FI) | 2023-12-27 | — | — | EP | claimed |
| WO-2023222019-A1 | LIGAND-DRUG CONJUGATE AND USE THEREOF | 成都百利多特生物药业有限责任公司 | 2023-11-23 | — | — | WO | claimed |
| CN-117085144-A | Ligand drug conjugate and application thereof | 成都百利多特生物药业有限责任公司 | 2023-11-21 | — | — | CN | claimed |
| WO-2023212704-A2 | MACROPINOCYTOSIS SELECTIVE NON-BINDING PROTEIN-DRUG CONJUGATES | TEZCAT BIOSCIENCES, INC. (US) | 2023-11-02 | — | — | WO | claimed |
| WO-2008039254-A2 | RNA NANOPARTICLES AND NANOTUBES | GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2008-04-03 | — | — | WO | claimed |
| EP-1786466-A2 | COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND AN ANTAGONIST OF A GENE PRODUCT FOR TREATING TUMORS | Genentech Inc. (US) | 2007-05-23 | — | — | EP | claimed |
| EP-1718145-A2 | CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS | Biosight Ltd. (IL) | 2006-11-08 | — | — | EP | claimed |
| EP-1622608-A2 | COMPOSITIONS AND METHODS FOR TREATING CANCER | Threshold Pharmaceuticals, Inc. (US) | 2006-02-08 | — | — | EP | claimed |
| WO-2006009805-A2 | COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND AN ANTAGONIST OF A GENE PRODUCT FOR TREATING TUMORS | GENENTECH, INC. (US) | 2006-01-26 | — | — | WO | claimed |
| EP-1569616-A2 | AN EXOPOLYSACCHARIDES DELIVERY SYSTEM FOR ACTIVE MOLECULES | Technologies Biolactis Inc. (CA) | 2005-09-07 | — | — | EP | claimed |
| WO-2005072061-A2 | CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS | BIOSIGHT LTD. (IL) | 2005-08-11 | — | — | WO | claimed |
| WO-2004087075-A2 | COMPOSITIONS AND METHODS FOR TREATING CANCER | THRESHOLD PHARMACEUTICALS, INC. (US) | 2004-10-14 | — | — | WO | claimed |
| WO-2004050057-A2 | AN EXOPOLYSACCHARIDES DELIVERY SYSTEM FOR ACTIVE MOLECULES | TECHNOLOGIES BIOLACTIS INC. (CA) | 2004-06-17 | — | — | WO | claimed |
| WO-2000040269-A2 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DISEASED TISSUES | LEE CLARENCE C (US) | 2000-07-13 | — | — | WO | claimed |